Overall volumes in futures & options currently stand at 2.89 crore contracts with a turnover of Rs. 15,60,701.67 crore.

Unless Nifty successfully moves past the hurdle of 10,650, we do not see any significant move in the index. On the downside, immediate support is seen around the level of 10,530, followed by 10,440.  Stocks in news: Venus Remedies, Tata Sponge Iron, SRF, Yes Bank, Lemon Tree, Infosys and Bank of Baroda.

The diminishing prospects of an all-out trade war and the rupee rallies to two-month high to close below 72-mark against the US dollar are a big boost for the Indian markets and thus we could see an optimistic start to the day. The SGX Nifty Index Future has nearly gained 0.38 per cent, suggesting Nifty may open around the level of 10,663.  

In the short-term, Rs 575-570 is likely to act as a strong support zone. While the momentum is likely to been seen when the stock manages to sustain above the recent swing of Rs. 637 per share.

Risk is as important as return while choosing an investment vehicle. Read on to find the most common type of risk and how to use them.

Non-banking finance company Sundaram Finance which holds a majority stake in Royal Sundaram has signed an agreement with Ageas International to divest 40 per cent stake for a total consideration of Rs. 1,520 crore.

Following stocks are close to their 52-week low as at 1.06 p.m. on November 15, 2018.

The markets on November 15, 2018 opened flat. BSE Sensex is trading at 35,270.79, up by 128.80 points and the Nifty is trading at 10,605.60, up by 29.30 points. 

Decitabine is an anti-cancer chemotherapy drug. This is used in the treatment of patients with myelodysplastic syndromes. The said Decitabine for Injection had annual sales of around US$ 135.9 million in the US market.

Yes Bank's Chairman, Ashok Chawla has resigned citing personal reasons after the CBI mentioned his name in the Aircel-Maxis case chargesheet.